Clinical trial Recruiting at 1 site Observational Ages 18 and up

Longitudinal study of patients with Abdominal Aortic Aneurysm in Barcelona

Official title: Observational Prospective Study of Individuals with Abdominal Aortic Aneurysm (AAA) to Monitor AAA Growth and Rupture Risk.

Run by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · NCT06827652 · Data updated 2026-11-12

This study is tracking patients with Abdominal Aortic Aneurysm in Barcelona to see how their condition changes over time and what happens to them until they need surgery or experience other serious outcomes.

More Abdominal Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment800 (estimated)
SponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Academic / other
Locations1 site (Barcelona, Catalonia)
StatusRecruiting
StartedOctober 5, 2020
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedFebruary 14, 2025
Trial IDNCT06827652 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with an infrarenal abdominal aortic diameter greater than 30 mm.

Probably not a fit

Patients with Type B dissections, saccular aneurysms, mycotic aneurysms, visceral aneurysms, or thoracic aneurysms may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Triple-A Barcelona Study (TABS) is a prospective longitudinal registry that recruits individuals diagnosed with Abdominal Aortic Aneurysm (AAA) at two hospitals in Barcelona. Participants are enrolled if they have an abdominal aortic diameter greater than 30 mm, with data collected through imaging, clinical assessments, and blood samples. The study aims to gather comprehensive medical histories and follow-up measurements until surgical intervention, rupture, or death occurs. This approach allows for a detailed understanding of AAA progression and patient outcomes.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of AAA progression and improve patient management strategies.

How similar studies have gone: Other studies focusing on AAA have shown success in understanding disease progression, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* clinical diagnosis of abdominal aortic aneurysm
* infrarenal abdominal aortic diameter greater than 30 mm

Exclusion Criteria:

* Type B dissections that progress to AAA
* saccular aneurysms
* mycotic aneurysms
* visceral aneurysms
* thoracic aneurysms.

Where it's running

  • Hospital de la Santa Creu i Sant Pau
    Barcelona, Catalonia, Spain
    Recruiting

Study contacts

  • Principal investigator: Maria Sabater-Lleal, PhD — Research Institute/hosp/santa Creu/pau
  • Study coordinator: Maria Sabater-Lleal, PhD
  • Email: msabater@santpau.cat
  • Phone: +34932919000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.